Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Other neoplasm 1Breast 1

Conditions

Stomach Neoplasms 1Precancerous Conditions 1HIV Infections 1Anus Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Argon Plasma Coagulation × Gastrointestinal × Clear all
NCT07161479 2026-02-06

Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)

Samsung Medical Center

Phase NA Recruiting
160 enrolled
GastrointestinalOther neoplasm

Precancerous Conditions, Stomach Neoplasms

NCT00428285 2019-05-01

Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Completed
20 enrolled
Gastrointestinal

Anus Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡